🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the best dose and how well bendamustine works wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2009-02-17
Trial ID
NCT00880815
Acute graft-versus-host-disease (aGvHD) is a typical complication after all...
Status
Recruiting
Location
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz
Start Date
2017-03-01
Trial ID
NCT03819803
Treatments Being Tested
This study evaluates the efficacy and safety of the combination of idarubic...
Status
Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2024-01-01
Trial ID
NCT06232694
About 60% of patients with DLBCL can be cured with a chemotherapy program. ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-07-01
Trial ID
NCT00712582
This study will find the maximum tolerated dose (MTD) of CYNK-001 which con...
Status
Unknown
Location
Colorado Blood Cancer Institute
Start Date
2020-05-12
Trial ID
NCT04309084
Treatments Being Tested
The goal of this clinical research study is to see if low intensity chemoth...
Status
Completed
Location
MD Anderson Cancer Center
Start Date
2002-10
Trial ID
NCT00048737
This phase II trial studies how well itacitinib works in preventing graft v...
Status
Withdrawn
Location
M D Anderson Cancer Center
Start Date
2020-09-22
Trial ID
NCT04127721
Patient Population: Patients with active myeloma (Stage II/III) that have c...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2010-01-15
Trial ID
NCT01045460
Chimeric Antigen Receptor T-Cell (CAR-T) immunotherapy is a rapidly develop...
Status
Not Yet Recruiting
Location
The Affiliated Hospital of Xuzhou Medical University
Start Date
2025-07-01
Trial ID
NCT07034755
Treatments Being Tested
Allogeneic transplantation is used to treat many malignant and non-malignan...
Status
Completed
Location
Duke University Health Systems
Start Date
2005-05
Trial ID
NCT00578942
Treatments Being Tested